시장보고서

상품코드

1807730

세계의 장기 칩(Organ-on-a-Chip) 시장 규모, 점유율, 동향, 업계 분석 : 제품 및 서비스별, 용도별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

Organ-on-a-Chip Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Services), By Application, By End Use, By Region - Market Forecast, 2025-2034

발행일: 2025년 08월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 115 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 장기 칩(Organ-on-a-Chip) 시장 규모는 2034년까지 32억 6,208만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

장기칩(Organ-on-a-Chip) 시장은 마이크로플루이딕스 장치를 사용하여 인체 장기의 구조와 기능을 시뮬레이션하는 기술이 중심이 되고 있습니다. 이 작은 플랫폼은 컴퓨터 메모리 스틱 정도의 크기로, 살아있는 인간 세포를 배열한 작은 유로로 만들어져 있습니다. 그 목적은 3D 세포배양이나 동물 실험과 같은 전통적인 방법보다 더 현실적이고 통제된 연구 환경을 만드는 것입니다. 이를 통해 과학자들은 장기가 어떻게 행동하는지 관찰하고, 질병을 모델링하고, 인간의 생물학과 매우 밀접한 방식으로 약물의 효과를 연구할 수 있습니다.

장기 칩(Organ-on-a-Chip) 시장은 주로 의약품 개발 및 독성학 연구 분야에서 새로운 솔루션의 필요성에 의해 주도되고 있습니다. 제약업계가 신약 개발의 효율성과 높은 임상시험 실패율을 낮추기 위해 노력하고 있는 가운데, 이 기술은 초기 단계의 시험에 유용한 툴을 제공합니다. 동시에, 윤리적 이슈와 정부 규제로 인해 동물실험을 대체할 수 있는 방법이 요구되고 있으며, 이러한 시스템에 대한 수요가 증가하고 있습니다. 시장은 또한 맞춤형 의료에 칩을 활용하고, 기술 개발자와 연구개발 기관의 공동 연구 증가와 같은 새로운 동향을 보고 있습니다.

장기칩(Organ-on-a-Chip) 시장 : 분석 개요

제품 및 서비스별로는 제품 분야가 2024년 가장 큰 점유율을 차지했습니다. 이는 주로 이 기술의 기반을 형성하는 물리적 장치, 기기 및 소모품의 본질적인 특성으로 인해 모든 연구 및 검사 용도에 필수적입니다.

용도별로는 신약개발 분야가 2024년 가장 큰 점유율을 차지했습니다. 이는 신약 개발의 효율성을 높이고 후기 임상시험의 높은 실패율을 낮추기 위한 제약업계의 노력에 있으며, 중요한 역할을 하고 있기 때문입니다.

최종 용도별로는 제약 및 생명공학 기업이 2024년 가장 큰 점유율을 차지했습니다. 특히 신약개발과 독성 스크리닝 개선을 위한 연구개발에 대한 막대한 투자가 업계 선도적 지위를 지원하고 있습니다.

북미는 세계 시장을 선도하는 지역입니다. 이 지역에는 대형 제약기업과 바이오테크 기업이 다수 존재하며, 연구개발에 많은 자금을 투자하고 있는 것이 이 지역의 우위를 높이는 주요 요인으로 작용하고 있습니다. 아시아태평양 시장은 빠르게 성장하고 있으며, 생명과학 및 의료 분야에 투자하는 국가가 증가하고 있습니다.

이 시장의 주요 기업에는 Emulate, Inc., MIMETAS BV, TissUse GmbH, CN Bio Innovations Ltd., InSphero AG, Nortis, Inc., Hesperos, Inc., AxoSim, Inc., Hµrel Corporation, Tara Biosystems, Inc.(Charles River Laboratories) 등이 있습니다.

시장 스냅숏
장기 칩(Organ-on-a-Chip) 시장 역학
- 촉진요인과 기회
  - 보다 안전하고 효과적인 Drug Discovery의 수요
  - 동물 실험의 대체 추진
- 억제요인과 과제
  - 높은 개발비와 복잡성
PESTLE 분석
장기 칩(Organ-on-a-Chip) 시장의 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 장기 칩(Organ-on-a-Chip) 시장 : 제품·서비스별

주요 분석 결과
서론
제품
서비스

제6장 세계의 장기 칩(Organ-on-a-Chip) 시장 : 용도별

주요 분석 결과
서론
Drug Discovery
독성 연구
기타

제7장 세계의 장기 칩(Organ-on-a-Chip) 시장 : 최종 용도별

주요 분석 결과
서론
학술연구기관
제약·바이오테크놀러지 기업
기타

제8장 세계의 장기 칩(Organ-on-a-Chip) 시장 : 지역별

주요 분석 결과
서론
- 장기 칩(Organ-on-a-Chip) 시장 분석 : 지역별(2020-2034년)
북미
- 북미 : 제품·서비스별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 제품·서비스별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 제품·서비스별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 제품·서비스별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 제품·서비스별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제10장 기업 개요

AxoSim, Inc.
CN Bio Innovations Ltd.
Emulate, Inc.
Hesperos, Inc.
Hµrel Corporation
InSphero AG
MIMETAS BV
Nortis, Inc.
Tara Biosystems, Inc.(Charles River Laboratories)
TissUse GmbH

KSA 25.09.25

The global organ-on-a-chip market size is expected to reach USD 3,262.08 million by 2034, according to a new study by Polaris Market Research. The report "Organ-on-a-Chip Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Services), By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The organ-on-a-chip market is centered on a technology that uses microfluidic devices to simulate the structure and function of human organs. These small platforms, often no larger than a computer memory stick, are made with tiny channels lined with living human cells. The goal is to create a more realistic and controlled environment for research than traditional methods such as 3D cell cultures or animal testing. This allows scientists to observe how organs behave, model diseases, and study the effects of drugs in a way that is highly relevant to human biology.

The organ-on-a-chip market is mainly driven by the need for new solutions in drug development and toxicology research. As the pharmaceutical industry works to make drug discovery more efficient and reduce the high failure rate of clinical trials, this technology offers a valuable tool for early-stage testing. At the same time, growing ethical concerns and government regulations are pushing for alternatives to animal testing, which has increased demand for these systems. The market is also seeing new trends, such as the use of these chips in personalized medicine and a rising number of collaborations between technology developers and research institutions.

Organ-on-a-Chip Market Report Highlights

By product & services, the products segment held the largest share in 2024. This is mainly attributed to the essential nature of the physical devices, instruments, and consumables that form the foundation of this technology and are crucial for all research and testing applications.

By application, the drug discovery segment held the largest share in 2024. This is because of its critical role in the pharmaceutical industry's efforts to develop new medications more efficiently and reduce the high rate of drug failures in late-stage clinical trials.

In terms of end use, the pharmaceutical and biotechnology companies segment held the largest share in 2024. Their significant investments in research and development, particularly for improving drug discovery and toxicology screening, drive their leading position in the industry.

North America is the leading region in the global market. The region's strong presence of major pharmaceutical and biotechnology companies and its significant funding for research and development are key factors driving its dominance. The Asia Pacific market is expanding rapidly, with a growing number of countries investing in the life sciences and healthcare sectors.

A few key players in the market include Emulate, Inc.; MIMETAS BV; TissUse GmbH; CN Bio Innovations Ltd.; InSphero AG; Nortis, Inc.; Hesperos, Inc.; AxoSim, Inc.; Hµrel Corporation; and Tara Biosystems, Inc. (Charles River Laboratories).

Polaris Market Research has segmented the organ-on-a-chip market report based on product & services, application, end use, and region:

By Product & Services Outlook (Revenue - USD Million, 2020-2034)

Products

Services

By Application Outlook (Revenue - USD Million, 2020-2034)

Drug Discovery

Toxicology Research

Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Organ-on-a-Chip Market Insights

4.1. Organ-on-a-Chip Market - Market Snapshot
4.2. Organ-on-a-Chip Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. The Demand for Safer and More Effective Drug Discovery
  - 4.2.1.2. Push for Alternatives to Animal Testing
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High development cost and complexity
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Organ-on-a-Chip Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Organ-on-a-Chip Market, by Product and Services

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
5.3. Products
- 5.3.1. Global Organ-on-a-Chip Market, by Elements, by Region, 2020-2034 (USD Million)
- 5.3.2. Instrument
- 5.3.3. Devices
  - 5.3.3.1. Liver-on-a-Chip
  - 5.3.3.2. Lung-on-a-Chip
  - 5.3.3.3. Intestine-on-a-Chip
  - 5.3.3.4. Kidney-on-a-Chip
  - 5.3.3.5. Heart-on-a-Chip
  - 5.3.3.6. Others
5.4. Services
- 5.4.1. Global Organ-on-a-Chip Market, by Chemicals, by Region, 2020-2034 (USD Million)

6. Global Organ-on-a-Chip Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
6.3. Drug Discovery
- 6.3.1. Global Organ-on-a-Chip Market, by Drug Discovery, by Region, 2020-2034 (USD Million)
6.4. Toxicology Research
- 6.4.1. Global Organ-on-a-Chip Market, by Toxicology Research, by Region, 2020-2034 (USD Million)
6.5. Others
- 6.5.1. Global Organ-on-a-Chip Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Organ-on-a-Chip Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
7.3. Academic & Research Institutes
- 7.3.1. Global Organ-on-a-Chip Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Global Organ-on-a-Chip Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
7.5. Others
- 7.5.1. Global Organ-on-a-Chip Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Organ-on-a-Chip Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Organ-on-a-Chip Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Organ-on-a-Chip Market - North America
- 8.3.1. North America: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
- 8.3.2. North America: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.3.4. Organ-on-a-Chip Market - U.S.
  - 8.3.4.1. U.S.: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.3.5. Organ-on-a-Chip Market - Canada
  - 8.3.5.1. Canada: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
8.4. Organ-on-a-Chip Market - Europe
- 8.4.1. Europe: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
- 8.4.2. Europe: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.4. Organ-on-a-Chip Market - UK
  - 8.4.4.1. UK: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.5. Organ-on-a-Chip Market - France
  - 8.4.5.1. France: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.5.2. France: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.3. France: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.6. Organ-on-a-Chip Market - Germany
  - 8.4.6.1. Germany: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.7. Organ-on-a-Chip Market - Italy
  - 8.4.7.1. Italy: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.8. Organ-on-a-Chip Market - Spain
  - 8.4.8.1. Spain: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.9. Organ-on-a-Chip Market - Netherlands
  - 8.4.9.1. Netherlands: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.10. Organ-on-a-Chip Market - Russia
  - 8.4.10.1. Russia: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.4.11. Organ-on-a-Chip Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
8.5. Organ-on-a-Chip Market - Asia Pacific
- 8.5.1. Asia Pacific: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.4. Organ-on-a-Chip Market - China
  - 8.5.4.1. China: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.4.2. China: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.3. China: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.5. Organ-on-a-Chip Market - India
  - 8.5.5.1. India: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.5.2. India: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.3. India: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.6. Organ-on-a-Chip Market - Malaysia
  - 8.5.6.1. Malaysia: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.7. Organ-on-a-Chip Market - Japan
  - 8.5.7.1. Japan: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.8. Organ-on-a-Chip Market - Indonesia
  - 8.5.8.1. Indonesia: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.9. Organ-on-a-Chip Market - South Korea
  - 8.5.9.1. South Korea: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.10. Organ-on-a-Chip Market - Australia
  - 8.5.10.1. Australia: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.5.11. Organ-on-a-Chip Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
8.6. Organ-on-a-Chip Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.6.4. Organ-on-a-Chip Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.6.5. Organ-on-a-Chip Market - UAE
  - 8.6.5.1. UAE: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.6.6. Organ-on-a-Chip Market - Israel
  - 8.6.6.1. Israel: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.6.7. Organ-on-a-Chip Market - South Africa
  - 8.6.7.1. South Africa: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.6.8. Organ-on-a-Chip Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
8.7. Organ-on-a-Chip Market - Latin America
- 8.7.1. Latin America: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
- 8.7.2. Latin America: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.7.4. Organ-on-a-Chip Market - Mexico
  - 8.7.4.1. Mexico: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.7.5. Organ-on-a-Chip Market - Brazil
  - 8.7.5.1. Brazil: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.7.6. Organ-on-a-Chip Market - Argentina
  - 8.7.6.1. Argentina: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)
- 8.7.7. Organ-on-a-Chip Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Organ-on-a-Chip Market, by Product and Services, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Organ-on-a-Chip Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Organ-on-a-Chip Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. AxoSim, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. CN Bio Innovations Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Emulate, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Hesperos, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Hµrel Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. InSphero AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. MIMETAS BV
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Nortis, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Tara Biosystems, Inc. (Charles River Laboratories)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. TissUse GmbH
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development